Verisfield UK Ltd. Greek Branch

• Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

  Phase 1, Completed, 49 people, 10 May 2016

Sources: clinicaltrials.gov